Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients.

Fang, C; Hernandez, P; Liow, K; Damiano, E; Zetterberg, H; Blennow, K; Feng, D; Chen, M; Maccecchini, M

Fang, C; Hernandez, P; Liow, K; Damiano, E; Zetterberg, H; Blennow, K; Feng, D; Chen, M; Maccecchini, M.

Affiliation

Fang C; Cheng Fang, 1055 Westlakes Dr #300, Annovis Bio, Berwyn, PA, USA fang@annovisbio.com phone # 610-727-3987.

J Prev Alzheimers Dis ; 10(1): 25-33, 2023.

Article in En | MEDLINE | ID: mdl-36641607

Subject(s)

Alzheimer Disease; Parkinson Disease; Humans; Alzheimer Disease/complications; Parkinson Disease/drug therapy; Parkinson Disease/complications; Treatment Outcome; Amyloid beta-Peptides/metabolism; Biomarkers/cerebrospinal fluid

Key words

Alzheimer's disease (AD); Parkinson's disease (PD); iron regulatory protein (IRP); iron response element (IRE); neurotoxic aggregating proteins

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Alzheimer Disease Type of study: Clinical_trials Limits: Humans Language: En Journal: J Prev Alzheimers Dis Year: 2023 Document type: Article Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google